Clinical Trial Update: Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib [Phase 3]

View source ↗

Summary

This clinical trial update notes a rollover study for participants previously enrolled in povorcitinib trials for hidradenitis suppurativa, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Povorcitinib (povorcitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa (HS) | Phase 3 | Status: RECRUITING